The addition of Bluetooth to glucose monitoring technology opens up new opportunities for connected systems. We are currently working on integration with the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) system.
Our first-generation Automated Insulin Delivery (AID) system is planned to include a Predictive Low Glucose Suspend (PLGS) algorithm. The algorithm will use CGM data to help predict future hypoglycemia (low blood sugar) before it happens and is designed to adjust insulin to help minimize the frequency and or duration of hypoglycemic events. The algorithm was developed internally in consultation with thought leaders in Automated Insulin Delivery and Artificial Pancreas research.
Timelines as of 11/1/2016:
- Feasibility study completed in August 2016
- Pivotal study planned to begin in Q1 2017
- Launch goal: Late 2017
Graph is for illustrative purposes only, and does not reflect individual results.
In July 2016 we announced a license agreement with TypeZero Technologies to accelerate development of a hybrid closed loop system. TypeZero’s AP technology includes a series of treat-to-target algorithms developed by TypeZero from initial research conducted at the University of Virginia. In 2016, this technology had been used in more than 28 clinical studies including more than 475 participants, with data referenced in a number of journal articles.3
Tandem, Dexcom and TypeZero are working together on the integration of their technologies into the NIH-funded International Diabetes Closed Loop (IDCL) Trial. A Tandem insulin pump and Dexcom G5 sensor will be included as part of a blood glucose control system that combines these devices with a smartphone running TypeZero’s inControl hybrid closed loop algorithm. Tandem is also working on development on a Tandem insulin pump that integrates the data from a Dexcom G6 sensor and TypeZero’s inControl algorithm directly into the pump’s touchscreen interface.